The Israeli Institute for Biological Research has released an antibody that neutralizes coronavirus, even among infected people.
The Israeli Institute for Biological Research (IIBR) and the Israeli Ministry of Defense have announced that the development phase of an antibody has been completed that would be effective in neutralizing SARS-Cow-2, known as coronavirus.
Through its Twitter account, the Israeli Defense Ministry confirmed the development of what could become the first antidote to cobweb-19.
According to the entities, the antidote is now moving from the development stage to the acceptance stage of pharmaceutical companies, which will enable mass production and commercialization.
The scientific development would be based on several proteins that are harmful to the human body and have already been tested in patients at risk for coronavirus.
Israel claims that IIBR is the first institution to achieve scientific success that meets all three parameters:
First, a new and refined monoclonal antibody containing harmful protein deficiency. Second, the antibody can neutralize the coronavirus, and third, the antibody was explicitly tested in aggressive coronavirus cases.
Meanwhile, the Israeli government has announced the complete removal of mobility restrictions imposed on citizens.
